Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized).
Saved in:
| Title: | Therapeutic Equivalence of Eyluxvi (Aflibercept) to Eylea in Neovascular Age-Related Macular Degeneration: ALTERA Trial (Randomized). |
|---|---|
| Authors: | Raczynska, Dorota1 (AUTHOR), Ernest, Jan2 (AUTHOR), Baumane, Kristine3 (AUTHOR), Sagong, Min4 (AUTHOR), Akiyama, Kunihiko5 (AUTHOR), Rauschning, Winrich6 (AUTHOR) wrpubl@gmail.com, Vajas, Attila7 (AUTHOR), Nowosielska, Agnieszka8 (AUTHOR), Dusova, Jaroslava9 (AUTHOR), Majtánová, Nora10 (AUTHOR), Oleksy, Piotr11 (AUTHOR), Kuneva, Irina12 (AUTHOR), Resch, Miklos13 (AUTHOR), Lange, Natalia1 (AUTHOR), Briede, Eliza3 (AUTHOR), Bajdik, Beáta7 (AUTHOR), Jeong, Areum4 (AUTHOR), Kozub, Barbara8 (AUTHOR), Papp, Andras13 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Feb2026, Vol. 15 Issue 2, p887-899. 13p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
